Patents for COVID-19 vaccines slow global supply, raise risk of new variants, advocates say
WHO data suggests richer countries have so far received 87 per cent of doses globally. Waiving patents on COVID-19 vaccines would remove "a legal hurdle" to companies and developing countries producing the shots and fixing a global supply problem, says an advocate with Oxfam Canada. "It allows them to produce it without having to [...]